IOL Chemicals raises ibuprofen capacity to 6200 tpa.

IOL Chemicals & Pharmaceuticals Ltd (IOLCP), a producer of active pharmaceutical ingredients (APIs), has increased the production capacity of ibuprofen to 6200 tonnes per annum (tpa) at Barnala plant in Punjab. Expansion follows a de-bottlenecking project undertaken by the company at an estimated cost of Rs 24 crores.

IOL Chemicals already exports ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) used as painkiller, to regulated and emerging markets, ie Europe, Latin America, Middle East, etc. With the recent approval from US FDA, the company is expanding its ibuprofen business in the US as well.

Being the only integrated ibuprofen player globally, IOL Chemicals aims to build and sustain the growth of its APIs business in coming years by exploring the higher value regulated markets.

BS